Soleno Therapeutics (SLNO) had the highest return between September 1, 2023 and November 3, 2023 by a mid-cap US stock, returning 367.3%.
| ASSET | DATE | % RETURN |
|---|---|---|
Soleno Therapeutics (SLNO) | 9/1/2023 - 11/3/2023 | 367.34% |
Immunitybio (IBRX) | 9/1/2023 - 11/3/2023 | 131.48% |
Scholar Rock (SRRK) | 9/1/2023 - 11/3/2023 | 98.24% |
Crinetics Pharmaceuticals (CRNX) | 9/1/2023 - 11/3/2023 | 75.43% |
Immunovant (IMVT) | 9/1/2023 - 11/3/2023 | 48.23% |
Frontline (FRO) | 9/1/2023 - 11/3/2023 | 34.75% |
Uranium Energy (UEC) | 9/1/2023 - 11/3/2023 | 31.96% |
Stride (LRN) | 9/1/2023 - 11/3/2023 | 30.54% |
NCR Atleos (NATL) | 9/1/2023 - 11/3/2023 | 30.11% |
HUTCHMED DRC (HCM) | 9/1/2023 - 11/3/2023 | 29.86% |
Frontier Communications Parent (FYBR) | 9/1/2023 - 11/3/2023 | 28.84% |
Mercury General (MCY) | 9/1/2023 - 11/3/2023 | 27.92% |
Wingstop (WING) | 9/1/2023 - 11/3/2023 | 27.86% |
Agilysys (AGYS) | 9/1/2023 - 11/3/2023 | 27.06% |
Adtalem Global Education (ATGE) | 9/1/2023 - 11/3/2023 | 24.89% |
TAL Education (TAL) | 9/1/2023 - 11/3/2023 | 24.49% |
Arcellx (ACLX) | 9/1/2023 - 11/3/2023 | 24.28% |
Lemonade (LMND) | 9/1/2023 - 11/3/2023 | 23.71% |
BGC (BGC) | 9/1/2023 - 11/3/2023 | 23.69% |
USA Compression Partners (USAC) | 9/1/2023 - 11/3/2023 | 23.17% |
Warrior Met Coal (HCC) | 9/1/2023 - 11/3/2023 | 22.92% |
Nuvalent (NUVL) | 9/1/2023 - 11/3/2023 | 22.63% |
Gap (GAP) | 9/1/2023 - 11/3/2023 | 22.53% |
FirstCash (FCFS) | 9/1/2023 - 11/3/2023 | 21.68% |
Abercrombie & Fitch (ANF) | 9/1/2023 - 11/3/2023 | 21.41% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
